Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Sheridan
Cedric Sheridan, Dondelange LU
| Patent application number | Description | Published |
|---|---|---|
| 20110056142 | AGGREGATE ABRASIVE GRAINS FOR ABRADING OR CUTTING TOOLS PRODUCTION - A method of forming aggregate abrasive grains for use in the production of abrading or cutting tools comprises providing abrasive core particles; coating these particles with adhesive, the adhesive comprising a binding agent and a solvent for the binding agent; separately dropping the adhesive-coated core particles onto a layer of abrasive peripheral particles and covering the dropped core particles with further peripheral particles, in such a way as to form aggregate particles, each of which comprises a core particle having peripheral particles attached to it; consolidating the aggregate particles by causing the solvent to evaporate, i.e. by letting the adhesive set. | 03-10-2011 |
| 20110056143 | INTERMEDIATE PRODUCT FOR USE IN THE PRODUCTION OF ABRADING OR CUTTING TOOLS - An intermediate product for use in the production of abrading or cutting tools has the form of a soft, easily deformable paste comprising powdery sinterable matrix material, binding agent and solvent for the binding agent, the paste having superabrasive particles dispersed therein, the superabrasive particles being individually encrusted within a coating of presintered material. | 03-10-2011 |
Edel Sheridan, Trondheim NO
| Patent application number | Description | Published |
|---|---|---|
| 20110072965 | CARBON MEMBRANES FROM CELLULOSE ESTERS - A process for the production of a carbon hollow fibre membrane comprising: | 03-31-2011 |
Gaetan Sheridan, Repentigny CA
| Patent application number | Description | Published |
|---|---|---|
| 20100008480 | Universal Internet Telephone System - There is described a method for setting up a call over the Internet between a Web-based phone and a phone device. The Web-based phone is loaded on a Java-enabled computing device. The call involves a Web application hosted on an external server capable of communication with a SIP Server on which the Web-based phone is pre-registered. Upon request from the computing device, the external server sends an HTTP message to a SIP Switch which in turn forwards a SIP NOTIFY message to the computing device through the SIP Server. The Web-based phone then pops up on the computing device and the call initiation can be confirmed. There is also described a platform independent Web-based phone as well as a Web application for auto-populating a contact directory from contacts on a social networking Web site. | 01-14-2010 |
Gerard Patrick Sheridan, Mayo IE
| Patent application number | Description | Published |
|---|---|---|
| 20080264031 | Baling and Bale Wrapping Apparatus and Methods - Baling apparatus ( | 10-30-2008 |
Joseph Michael Sheridan, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20100261732 | 1, 2, 4 -TRIAZOLE DERIVATIVES AS SEROTONERGIC MODULATORS - The invention relates to novel 5-hydroxytryptamine (5-HT) receptor modulator compounds of formula (I); wherein A, B, R | 10-14-2010 |
Paul Sheridan, East Sussex GB
| Patent application number | Description | Published |
|---|---|---|
| 20100049673 | Forest Factory Valuation Model - Apparatuses, computer media, and methods for determining a value of a forest factory. A stump land value component and a biomass component of a forest factory are determined. A value of the forest factory is obtained by combining the components. The stump land value component may be normalized by a crop rotation time period. A carbon value component of a forest factory may be determined and the value of the forest factory adjusted. A land parcel may be partitioned into land partitions, in which forest parameters are associated with each land partition. A stump land value component, a biomass fuel value component, and a carbon credit value component may be determined from the land partitions. The carbon credit value component may be determined a percentage of coniferous trees, deciduous trees, and corresponding constant values of oxygen generation. | 02-25-2010 |
Paul J. Sheridan, Maryburgh Woods IE
| Patent application number | Description | Published |
|---|---|---|
| 20100165522 | DISTRIBUTION OF ELECTROSTATIC DISCHARGE (ESD) CIRCUITRY WITHIN AN INTEGRATED CIRCUIT - Embodiments of the present disclosure provide an integrated circuit (IC) or semiconductor device. This semiconductor device includes a number of I/O pads or bumps on an outer surface of the semiconductor device, a number of electrostatic discharge (ESD) protection cells and functional modules. Individual ESD protection cells couple to and are downstream of individual I/O pads. Functional modules coupled to and are downstream of individual ESD protection cells. The ESD protection cells protect circuitry within the functional module from electrostatic discharge events. A rail clamp may provide an ESD discharge path between a first power supply bus and a second power supply bus. The ESD protection cells may be collected in groups to form clusters (with linear or irregular placement patterns). These clusters may be distributed autarchically across the semiconductor device overlapping one or more functional modules or within spaces or gaps between the functional modules. | 07-01-2010 |
Rose Mary Sheridan, Little Chesterford GB
| Patent application number | Description | Published |
|---|---|---|
| 20090176819 | 39-Desmethoxy-39-Methyl Derivatives of Rapamycin - The present invention relates to novel 39-desmethoxy-39-methylrapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 39-desmethoxy-39-methylrapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections. | 07-09-2009 |
Rose Mary Sheridan, Northchurch GB
| Patent application number | Description | Published |
|---|---|---|
| 20110172189 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. Formula (I). | 07-14-2011 |
| 20110190302 | Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 08-04-2011 |
Rose Mary Sheridan, Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20090209572 | 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders - The present invention relates to novel 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections. | 08-20-2009 |
Rose Mary Sheridan, Nr Saffron Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20100081682 | 39-Desmethoxy Derivatives of Rapamycin - The present invention relates to 39-desmethoxyrapamycin derivatives and their uses thereof. The present invention provides for the use of these compounds in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections. | 04-01-2010 |
Rose Mary Sheridan, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20100061994 | MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF - The present invention relates to medical uses of 39-desmethoxyrapamycin analogues. | 03-11-2010 |
Rose Mary Sheridan, Saffron Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20090209494 | 21-DEOXYMACBECIN ANALOGUES USEFUL AS ANTITUMOR AGENTS - The present invention relates to 21-deoxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and or prophylaxis of cancer or B-cell malignancies. | 08-20-2009 |
Scott Sheridan, Belleville CA
| Patent application number | Description | Published |
|---|---|---|
| 20120118708 | Dust and particulate containment system for conveyors - A dust and particulate containment system for an open sided gallery conveyor, having a movable curtain for covering the open side of the conveyor and a trough positioned within and extending along a length of the conveyor. A rail is arranged within the conveyor and a carriage, having an opening for transferring bulk materials therethrough via a sealed connection to a cross conveyor, is positioned to move along this rail. Sealing strips in the trough retain the curtain tautly in place and seal the open side of the conveyor. As each carriage moves along the rail, a spreader frame attached to the carriage biasingly opens the sealing strips, and temporarily frees the curtain from being retained, so that the freed curtain is lifted over the carriage to avoid covering the opening in the carriage, so that transfer of bulk materials in the conveyor can occur through the opening. | 05-17-2012 |
Simon Sheridan, Broom GB
| Patent application number | Description | Published |
|---|---|---|
| 20110278483 | VALVE - A valve device ( | 11-17-2011 |